Abstract
The fate of patients with Hodgkin’s disease who relapse or fail to achieve complete remission with first line treatment is ominous. Second line combination chemotherapy can produce good remission rates although cures are uncommon (Hagemeister et al, 1987; Santoro et al, 1986). Of those patients achieving complete remissions, 15–20% will develop a second malignancy as a chemotherapy-related side effect (Valagussa et al, 1986). Therefore new non-mutagenic agents are needed for the treatment of this disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bernhard, M.I., Foon, K.A., Oeltmann, T.N., Key, M.E., Hwang, K.M., Clarke, G.C., Christensen, W.L., Hoyer, L.C., Hanna, M.G., Jr. and Oldham, R.K., 1983, Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A-chain, Cancer Res. 43:4420.
Blakey, D.C., Watson, G.J., Knowles, P.P. and Thorpe, P.E., 1987, Effect of chemical deglycosylation of ricin A-chain on the in vivo fate and cytotoxic activity of an immunotoxin ccmposed of ricin A-chain and anti-thy 1.1. antibody. Cancer Res., 47:947.
Chittal, S.M., Caveriviere, P., Schwarting, R., Gerdes, J., Al Saati, T., Rigal-Huguet, F., Stein, H. and Delsol, G., 1988, Monoclonal antibodies in the diagnosis of Hodgkin’s disease. The search for a rational panel. Am. J.Surg.Path., 12:9.
Engert, A., Burrows, F., Jung, W., Tazzari, P.L., Stein, H., Pfreundschuh, M., Diehl, V. and Thorpe, P., 1990, Evaliiation of ricin A-chain- containing immunotoxins directed against CD30 as potential reagents for the treatment of Hodgkin’s disease. Cancer Res., in press.
Fraker, P.J. and Speak, J.C., 1978, Protein and cell membrane iodination with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3,6 diphenylglycouril, Biochem. Biophys. Res. Comm., 80:849.
Fulton, R.J., Blakey, D.C., Knowles, P.P., Uhr, J.W., Thorpe, P.E. and Vitetta, E.S., 1986, Purification of ricin Al, A2 and B chains and characterization of their C5rtotoxicity, J.Biol.Chem., 261:5314.
Hagemeister, F.B., Tannir, N., McLaughlin, P., Salvador, P., Riggs, S., Velasquez, W.S. and Cabanillas, F., 1987, MIME chemotherapy (Methyl- GAG, Ifosfamide, Methothrexate, Etoposide) as treatment for recurrent Hodgkin’s disease, Clin.Oncol., 5:556.
Hsu, S-M., Ho, Y-S. and Hsu, P-L., 1987, Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Stemberg cells, J.Natl.Cancer Inst., 5:1091.
Hwang, K.M., Foon, K.A., Cheung, P.H., Pearson, J.W. and Oldham, R.K., 1984, Selective antitumor effect on LIO Hepatocarcinoma cells of a potent immunoconjugate ccanposed of the A-chain of abrin and a monoclonal antibody to a hepatoma-associated antigen. Cancer Res., 44:4578.
Knowles, P.P. and Thorpe, P.E., 1987, Purification of immunotoxins containing ricin A-chain and abrin A-chain using Blue Sepharose CL-6B, Anal.Biochem., 160:440.
Leonard, J.E., Johnson, D.E., Shawler, D.L. and Dillman, R.O., 1988, Inhibition of human T-cell tumor growth by TlOl-ricin A-chain in an athymic mouse model. Cancer Res., 48:4862.
Pfreundschuh, M., Mommertz, E., Meissner, M., Feller, A.C., Hassa, R., Krueger, G.R.F. and Diehl, V., 1988, Hodgkin and Reed-Stemberg cell associated monoclonal antibodies HRS-1 and HSR-2 react with activated cells of lymphoid and monocytoid origin. Anticancer Res., 8:217.
Santoro, A., Viviani, P., Valagussa, P., Bonfante, V. and Bonadonna, G., 1986, CCNU, Etoposide and Prednimustine (CEP) in refractory Hodgkin’s disease, Semin.Oncol., 13(Suppl. 1):23.
Scatchard, G., 1949, The attraction of proteins for small molecules and ions, Ann.N.Y.Acad.Sci., 51:660.
Schaadt, M., Diehl, V., Stein, H., Fonatsch, C. and Kirchner, H.H., 1980, Two neoplastic cell lines with imique features derived from Hodgkin’s disease, Int.J.Cancer, 26:723.
Schwab, U., Stein, H., Gerdes, J., Lembke, H., Kirchner, H., Schaadt, M. and Diehl, V., 1982, Production of a monoclonal antibody specific for Hodgkin and Stemberg-Reed cells of Hodgkin’s disease and a subset of normal lymphoid cells. Nature, 299:65.
Schwarting, R., Gerdes, J. and Stein, H., 1987, Ber-H2: a new monoclonal antibody of the Ki-1 family for the detection of Hodgkin’s disease in formaldehyde-fixed tissue sections, to: “Leucocyte Typing III”, J.A. McMichael, ed., Oxford University Press, Oxford.
Stein, H., Mason, D.Y., Gerdes, J., O’Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lembke, H., Schwarting, R. and Lennert, K., 1985, The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Stemberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66:848.
Thorpe, P.E., Detre, S.I., Foxwell, B.M.J., Brown, A.N.F., Skilleter, D.N, Wilson, G., Forrester, J.A. and Stirpe, F., 1985, Modification of the carbohydrate in ricin with me taper iodate-cyanoborohydride mixtures. Effect on toxicity and in vivo distribution, Eur. J.Biochem., 147:197.
Thorpe, P.E., Wallace, P.M., Knowles, P.P. Reif, M.G., Brown, A.N.F., Watson, G.J., Knyba, R.E., Wawrzamczak, E.J. and Blakey, D.C., 1987, New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo, Cancer Res., 47:5924.
Thorpe, P.E., Wallace, P.M., Knowles, P.P., Reif, M.G., Brown, A.N.F., Watson, G.J., Blakey, D.C. and Newell, D.R., 1988, Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages. Cancer Res., 48:6396.
Valagussa, P., Santora, A., Fossati-Belloni, F., Banti, A. and Bonadonna, G., 1986, Second acute leukemia and other malignancies following treatment for Hodgkin’s disease, J.Clin.Oncol., 4:830.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Engert, A., Thorpe, P. (1990). Antitumor Effects of Six Ricin A-Chain Immunotoxins of Potential Use in the Treatment of Hodgkin’S Disease. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Targeting of Drugs 2. NATO ASI Series, vol 199. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-9001-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9001-5_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-9003-9
Online ISBN: 978-1-4684-9001-5
eBook Packages: Springer Book Archive